Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
about
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatmentLymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersUse of thiopurines in inflammatory bowel diseaseIntestinal cancer in inflammatory bowel disease: natural history and surveillance guidelinesReview article: acute severe ulcerative colitis - evidence-based consensus statements.Do inflammatory bowel disease therapies cause cancer?Cancer and immunomodulators in inflammatory bowel diseases.Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.Effect of Medications on Risk of Cancer in Patients With Inflammatory Bowel Diseases: A Population-Based Cohort Study from Olmsted County, MinnesotaExtracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.Recent advances using immunomodulators for inflammatory bowel disease.The role and advances of immunomodulator therapy for inflammatory bowel disease.Management of Inflammatory Bowel Disease in the Elderly.Thiopurines and Methotrexate Use in IBD Patients in a Biologic Era.Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.Primary rectal diffuse large B-cell lymphoma associated with ulcerative colitis: a case report.Two rare cases of Epstein-Barr virus-associated lymphoproliferative disorders in inflammatory bowel disease patients on thiopurines and other immunosuppressive medications.Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
P2860
Q26745456-1F0767EC-82AD-4883-9CA8-1B694D20688DQ26776151-D4FC094C-F228-4A41-98D6-CC6E36FE8E18Q26824662-5BC9777E-BF5F-40E8-AA26-33586C8F455EQ26826827-89D94913-8FBB-485C-A749-85564D1EB8F6Q34528270-E5A1B763-ABCD-425E-B319-C6EA3F7C2DE6Q34613890-5C19D54D-C9AA-4DC4-BDBC-7723AEAEAE09Q35534959-68932706-90EF-434E-90E8-0E395197B206Q35625473-E7B37041-263B-4553-8064-B3DA50A36D5AQ35690314-24AA6ED6-F268-4037-B92B-349D1C5D6AFEQ36378458-F4C2DBA0-19F7-4D7E-8D04-F3EEAD9EFEA8Q38055211-6B47E1F6-8C9A-4F7B-9057-C0DEC8B7DDF4Q38081399-7D6C86A4-BFC0-47D2-B571-17D36AA9980FQ38237701-E2D9C4C9-FA86-4558-B762-3BDC762EB985Q38844393-911AF068-B5E0-4DAD-998C-144CEEE9DD8DQ39119181-6D1E6AC3-66B9-44A2-8AA4-706FFA51560BQ41033177-8CEF77A1-6C65-4E5A-859C-DD290ACAED83Q41293583-ECF6F6F0-0037-4BC5-8CA4-5F0F97302E6BQ41358364-C9DA0A39-4AC5-4AFA-BCDD-F9E1C09AE578Q42249643-BB515811-E20D-4AB4-8E05-D3D78FD368B5Q44786560-051D6DF3-EF83-4B18-AE81-B791B21C40D8
P2860
Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@en
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@nl
type
label
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@en
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@nl
prefLabel
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@en
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@nl
P2093
P2860
P50
P356
P1476
Excess primary intestinal lymp ...... th inflammatory bowel disease.
@en
P2093
Bernard Flourié
CESAME Study Group
David Laharie
Eric Lerebours
Jean-Louis Dupas
Marc Maynadié
Matthieu Allez
Nicole Brousse
P2860
P304
P356
10.1002/IBD.22889
P577
2012-01-23T00:00:00Z